Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information



Venture capital fund, 2/2011 $100M


50 Monument Road
Suite 201
Bala Cynwyd, PA, 19004


Managing Partner
Managing Partner
Managing Partner
Founding Partner
Vice President
Senior Associate


Osage University Partners

Osage University Partners (“OUP”) is a new venture capital fund that invests in university start-ups. OUP partners with high quality universities to serve as their coinvestment vehicle in start-ups that are licensing their technology.

Recent Milestones


Company Date Round Size Participants
Kolltan Pharmaceuticals 3/2014Series D$60M5
Infinio 12/2013Series B$12M4
Immune Design 10/2013Series C$49M6
Sideris Pharmaceuticals 10/2013Series A$32M3
Otonomy 9/2013Series C$45.9M8
Evolv Technologies 8/2013Venture Round$11.8M4
Kymeta 6/2013Series C$50M5
Effector Therapeutics 5/2013Venture Round$45M7
Skytree 4/2013Series A$18M5
MC10 12/2012Series C$10M7
Urjanet 12/2012Series B$2M2
Applied Genetics Technologies Corporation 11/2012Series B$37.5M6
Cardioxyl Pharmaceuticals 11/2012Series B$28M4
Clinipace WorldWide 10/2012Series C$9M1
Mirna Therapeutics 10/2012Series C$34.5M5
Atterocor 8/2012Series A$16M3
SolarBridge Technologies 5/2012Series D$25M3
Receptos 3/2012Venture Round$30M6
Liquid Light 12/2011Series A$8.5M5
Sera Prognostics 11/2011Series A$19.3M5
Tangent Medical Technologies 11/2011Series A$4.5M2
Cleave Biosciences 10/2011Series A$44M6
Clinipace WorldWide 9/2011Series C$15M4
MC10 6/2011Series B$12.5M4
SolarBridge Technologies 6/2011Series C$19M4
Aerie Pharmaceuticals 3/2011Series B$41.4M5
Immune Design 7/2010Series B$32M5
MC10 7/2010Series A$6.21M4
CampaignerCRM 1/2010Venture Round$8M3
Luxtera 12/2009Series B$10M7
Virdante Pharmaceuticals 11/2009Series A$30M6
Corridor Pharmaceuticals 10/2009Series A$10.8M4
Gevo 8/2009Venture Round$40M7
Avid Radiopharmaceuticals 5/2009Series D$34.5M8
Kolltan Pharmaceuticals 7/2008Series A$40M5



  1. Osage closes lid on $100M war chest for university start-ups ( [edit]
  2. Wall Street Journal ( [edit]
  3. Kolltan Pharmaceuticals Completes $60M Series D Financing ( [edit]
  4. Infinio Systems Closes $12M Series B Financing ( [edit]
  5. Immune Design Closes an up to $49M Series C Financing ( [edit]
  6. Sideris Pharmaceuticals completes $32m equity financing ( [edit]
  7. Otonomy completes $45.9m Series C financing ( [edit]
  8. Evolv Technologies Raises $11.8M in Funding ( [edit]
  9. Kymeta Closes $50M Series C Financing ( [edit]
  10. Effector Therapeutics snags $45M venture round from A-list backers ( [edit]
  11. Skytree Secures $18 Million in Funding to Fuel Explosive Growth in the Big Data Analytics Market ( [edit]
  12. New Strategic Investors Team Up with MC10 to Revolutionize Healthcare ( [edit]
  13. SEC ( [edit]
  14. Applied Genetic Technologies Corporation Lands $37.5 Million in Venture Capital Funding ( [edit]
  15. Cardioxyl Pharmaceuticals Raises $28 Million in Series B Financing Led by OrbiMed Advisors ( [edit]
  16. Clinipace Announces $9 Million Series C2 Funding ( [edit]
  17. Mirna Therapeutics Completes $34.5M Series C Financing ( [edit]
  18. Atterocor Raises $16M in Series A Funding ( [edit]
  19. SolarBridge Technologies Raises $25M in Series D Funding ( [edit]
  20. Osage University Partners Source [edit]
  21. Osage University Partners [edit]
  22. Sera Secures $19.3 million Financing; Appoints Greg C. Critchfield, MD as Chief Executive Officer ( [edit]
  23. Tangent Medical Closes $4.5 Million Series A Financing ( [edit]
  24. Cleave Biosciences Raises $42M in Series A Financing ( [edit]
  25. Clinipace Worldwide Closes $15M Series C Funding Round ( [edit]
  26. MC10 taps Braemar to lead new $12.5M Series B round ( [edit]
  27. SolarBridge Technologies Secures $19m in Series C Funding ( [edit]
  28. SEC ( [edit]
  29. Immune Design Nabs $32M for Targeted Vaccines ( [edit]
  30. SEC D ( [edit]
  31. Landslide raises $8M, appoints former Mzinga CEO Faulk ( [edit]
  32. Osage University Partners Source [edit]
  33. Virdante Pharmaceuticals, Inc.: Series A $30M ( [edit]
  34. Corridor Pharmaceuticals-Receives-$10,750,000 ( [edit]
  35. Osage University Partners Source [edit]
  36. Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing ( [edit]
  37. Osage University Partners [edit]
Edit This Page
Last Edited 3/26/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy